VanEck Pharmaceutical ETF (PPH)
NASDAQ: PPH
· Real-Time Price · USD
94.26
3.90 (4.32%)
At close: Oct 01, 2025, 3:59 PM
94.75
0.52%
After-hours: Oct 01, 2025, 07:54 PM EDT
PPH Holdings List
As of Sep 30, 2025
The VanEck Pharmaceutical ETF is an equity ETF with a total of 25 individual holdings.
The top holdings are Eli Lilly and Company at 19.54%, Novartis at 9.70%, Novo Nordisk A/S at 7.97%, Merck & at 7.18%, and Pfizer at 4.93%.
25
72.84%
Equity
531.7M
22.77
0.3600%
Sector Allocation
| Rank | Symbol | Name | Price | % Change | Shares | % Weight |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and C... | 825.71 | +8.22% | 141.85K | 19.54% |
| 2 | NVS | Novartis AG | 131.70 | +2.70% | 412.24K | 9.70% |
| 3 | NVO | Novo Nordisk A/... | 59.18 | +6.65% | 757.23K | 7.97% |
| 4 | MRK | Merck & Co., In... | 90.12 | +7.38% | 481.57K | 7.18% |
| 5 | PFE | Pfizer Inc. | 27.23 | +6.89% | 1.09M | 4.93% |
| 6 | MCK | McKesson Corpor... | 765.13 | -0.96% | 34.1K | 4.93% |
| 7 | ABBV | AbbVie Inc. | 244.39 | +5.55% | 113.8K | 4.82% |
| 8 | JNJ | Johnson & Johns... | 186.02 | +0.32% | 137.01K | 4.72% |
| 9 | GSK | GSK plc | 45.52 | +5.47% | 594.69K | 4.63% |
| 10 | SNY | Sanofi | 49.76 | +5.42% | 510.71K | 4.42% |
| 11 | ZTS | Zoetis Inc. | 146.93 | +0.42% | 161.19K | 4.37% |
| 12 | BMY | Bristol-Myers S... | 47.41 | +5.13% | 510.82K | 4.28% |
| 13 | AZN | AstraZeneca PLC | 84.36 | +9.96% | 298.04K | 4.19% |
| 14 | COR | Cencora, Inc. | 311.71 | -0.26% | 64.14K | 3.75% |
| 15 | HLN | Haleon plc | 9.02 | +0.50% | 1.76M | 2.95% |
| 16 | TAK | Takeda Pharmace... | 14.76 | +0.82% | 967.44K | 2.68% |
| 17 | TEVA | Teva Pharmaceut... | 20.05 | -0.74% | 476.88K | 1.73% |
| 18 | VTRS | Viatris Inc. | 10.09 | +1.92% | 323.19K | 0.59% |
| 19 | JAZZ | Jazz Pharmaceut... | 136.90 | +3.87% | 21.97K | 0.54% |
| 20 | ELAN | Elanco Animal H... | 20.80 | +3.25% | 117.73K | 0.44% |
Page 1 of 2